2269:HKG
WuXi Biologics (Cayman) Inc
48,20Â HKD
arrow_downward
−0,90%(−0,44) 1 D
16. okt., 16:08:14 GMT+8 · HKD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for 2269 …
Ã…pne
49,98Â HKD
Høy
50,85Â HKD
Lav
45,82Â HKD
Markedsverdi
198,43Â mrd.
Snittvolum
30,42Â mill.
Volum
55,18Â mill.
P/E-forhold
34,48
52 u høy
58,00Â HKD
52Â u lav
28,48Â HKD
EPS
1,40Â HKD
Utestående aksjer
1,23Â mrd.
Antall ansatte
15k
Ã…pne
49,98Â HKD
Høy
50,85Â HKD
Lav
45,82Â HKD
Markedsverdi
198,43Â mrd.
Snittvolum
30,42Â mill.
Volum
55,18Â mill.
P/E-forhold
34,48
52 u høy
58,00Â HKD
52Â u lav
28,48Â HKD
EPS
1,40Â HKD
Utestående aksjer
1,23Â mrd.
Antall ansatte
15k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Finansavisen
·
for 2 døgn siden
Wall Street endte opp: Statsrentenefallerkraftig
Yahoo Finance
·
for 1 time siden
Michael Burry Warns of a Stock Market ‘Supervolcano’
The Motley Fool
·
for 55 minutter siden
A Record Number of S&P 500 Companies Issued Upbeat Guidance Before Earnings Season. Should You Buy an Index Fund Now?
MarketBeat
·
for 1 time siden
Fox Corporation (NASDAQ:FOX) Stock Has Average Price Target of $76.56
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Om WuXi Biologics (Cayman) Inc
Administrerende direktørZhisheng Chen
Ansatte14,7k
Grunnlagt2010
Hovedkontor-
Sektor-
Nettstedwuxibiologics.com